Related Experiment Video

Updated: Jun 21, 2026

Probing High-density Functional Protein Microarrays to Detect Protein-protein Interactions
08:07

Probing High-density Functional Protein Microarrays to Detect Protein-protein Interactions

Published on: August 2, 2015

Protein-binding microarrays: probing disease markers at the interface of proteomics and genomics

Jan Kerschgens1, Tanja Egener-Kuhn, Nicolas Mermod

  • 1Institute of Biotechnology, University of Lausanne, CH-1015 Lausanne, Switzerland.

Trends in Molecular Medicine
|August 12, 2009
PubMed

Insights

Protein-binding microarrays (PBMs) offer a novel method for identifying DNA-binding proteins. These PBMs can serve as rapid, unbiased molecular markers for diagnosing diseases like cancer.

Area of Science:

  • Molecular Biology
  • Genomics
  • Biotechnology

Background:

  • DNA-binding proteins are crucial for fundamental cellular processes including gene regulation, DNA repair, and cell division.
  • Investigating the role of DNA-binding proteins in diseases like cancer is vital for developing new diagnostic tools.
  • Current microarray-based methods for studying these proteins face challenges in routine clinical diagnostics.

Purpose of the Study:

  • To review alternative approaches to current microarray techniques for studying DNA-binding proteins.
  • To highlight the potential of protein-binding microarrays (PBMs) as a diagnostic tool.
  • To discuss the application of PBMs in identifying molecular markers for diseases.

Main Methods:

  • Review of recent studies utilizing protein-binding microarrays (PBMs).
  • PBMs probe interactions between proteins from cell/tissue extracts and extensive DNA sequence libraries.
  • Analysis of PBMs for rapid and unbiased characterization of DNA-binding proteins.

Main Results:

  • PBMs enable the study of DNA-binding protein interactions in complex biological samples.
  • These novel PBM approaches offer a faster and more objective method compared to traditional assays.
  • Demonstrated utility of PBMs in identifying disease-specific DNA-binding protein markers.

Conclusions:

  • Protein-binding microarrays (PBMs) represent a promising advancement in the study of DNA-binding proteins.
  • PBMs can serve as effective molecular markers for disease progression, including cancer and infectious diseases.
  • This technology facilitates rapid and unbiased characterization, aiding in disease diagnosis and research.

More Related Videos

Extracellular Protein Microarray Technology for High Throughput Detection of Low Affinity Receptor-Ligand Interactions06:01

Extracellular Protein Microarray Technology for High Throughput Detection of Low Affinity Receptor-Ligand Interactions

Published on: January 7, 2019

Chemically-blocked Antibody Microarray for Multiplexed High-throughput Profiling of Specific Protein Glycosylation in Complex Samples13:21

Chemically-blocked Antibody Microarray for Multiplexed High-throughput Profiling of Specific Protein Glycosylation in Complex Samples

Published on: May 4, 2012

Related Concept Videos

Proteomics01:33

Proteomics

A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term proteomics...
DNA Microarrays02:34

DNA Microarrays

Microarrays are high-throughput and relatively inexpensive assays that can be automated to analyze large quantities of data at a time. They are used in genome-wide studies to compare gene or protein expression under two varied conditions, such as healthy and diseased states. Microarrays consist of glass or silica slides on which probe molecules are covalently attached through surface functionalization. Most commonly, the slides are prepared through the chemisorption of silanes to silica...
Protein-protein Interfaces02:04

Protein-protein Interfaces

Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a polypeptide...
Protein Networks02:26

Protein Networks

An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...